5-Amino-1MQ is a small molecule compound (not a peptide) that targets the NNMT enzyme — a recently identified regulator of fat cell metabolism and NAD+ homeostasis. It is commonly offered alongside peptide research compounds due to overlapping metabolic research applications.
Research Applications
NNMT inhibition research, adipose tissue metabolism, NAD+ salvage pathway, obesity models, and cellular energy expenditure studies.
Dosage Information (Research Use)
Animal model research: 2-10 mg/kg. Oral bioavailable compound. Research use only.
Reconstitution & Handling
N/A — orally bioavailable compound, typically supplied as capsules or powder.
Half-Life & Pharmacokinetics
Not fully characterized in published human pharmacokinetic data.
Reported Observations in Literature
Limited adverse effect data — primarily animal model studies. No significant toxicity reported at research doses in available literature.
Key Research References
- Neelakantan H, et al. “Selective and membrane-permeable small molecule inhibitors of NNMT cause direct, rapid reductions in white adipose tissue.” Biochem J. 2018